BridgeBio Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-797.12	-535.76	-643.2	-481.18	-562.54	-448.72
Depreciation & Amortization	5.37	6.08	6.49	6.77	5.84	1.46
Loss (Gain) From Sale of Assets	-	-178.32	1.24	6.26	-	-
Asset Writedown & Restructuring Costs	0.27	0.27	-	12.72	-	4.73
Loss (Gain) From Sale of Investments	-	-8.14	-18.31	8.22	-29.91	-
Loss (Gain) on Equity Investments	60.51	31.18	-	-	-	-
Stock-Based Compensation	128.51	95.8	108.71	91.56	99.51	58.46
Other Operating Activities	106.26	36.12	12.29	-91.92	-6.43	-30.57
Change in Accounts Receivable	-116.04	-2.97	15.33	15.17	-19.75	-
Change in Accounts Payable	5.34	1.51	2.78	-0.35	2.83	-0.74
Change in Unearned Revenue	-8.18	21.88	-5.44	15.26	-	-
Change in Other Net Operating Assets	54.51	11.63	-7.61	-2	12.52	15.67
Operating Cash Flow	-584.82	-520.73	-527.72	-419.49	-497.93	-399.71
Capital Expenditures	-1.11	-0.93	-1.31	-4.82	-13.25	-7.52
Sale of Property, Plant & Equipment	-	-	-	10	-	-
Cash Acquisitions	-	-	-	-	13.65	-
Divestitures	-	-0.14	-0.5	-	-	-
Sale (Purchase) of Intangibles	-11.69	-7.98	-	-1.5	-35	-
Investment in Securities	-2.88	44.15	55.84	339.47	-166.23	-38.72
Other Investing Activities	2.3	25.68	-	110	-	-6.76
Investing Cash Flow	-13.37	60.78	54.03	453.15	-200.83	-52.99
Long-Term Debt Issued	-	950	-	-	1,204	550
Long-Term Debt Repaid	-	-473.42	-	-20.49	-124.12	-
Net Debt Issued (Repaid)	916	476.58	-	-20.49	1,080	550
Issuance of Common Stock	23.79	322.9	459.22	8.08	20.46	14.13
Repurchase of Common Stock	-56.48	-7.53	-6.88	-1.56	-204.75	-75.71
Other Financing Activities	-47.9	-43.5	-0.8	0.84	-158.95	-41.23
Financing Cash Flow	835.41	748.46	451.54	-13.13	736.45	447.19
Net Cash Flow	237.22	288.51	-22.15	20.52	37.69	-5.52
Free Cash Flow	-585.93	-521.66	-529.03	-424.32	-511.18	-407.23
Free Cash Flow Margin	-165.62%	-235.08%	-5686.62%	-546.46%	-733.23%	-4936.74%
Free Cash Flow Per Share	-3.08	-2.80	-3.25	-2.88	-3.54	-3.45
Cash Interest Paid	56.78	91.34	61.11	54.44	29.77	15.32
Levered Free Cash Flow	-268.52	-288.27	-249.07	-285.88	-301.13	-250.16
Unlevered Free Cash Flow	-169.04	-226.21	-198.26	-235.61	-271.89	-227.25
Change in Working Capital	-87.73	32.04	5.06	28.08	-4.4	14.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.